Mackenzie Financial Corp Buys Shares of 7,133 Evolent Health, Inc. (NYSE:EVH)

Mackenzie Financial Corp acquired a new position in Evolent Health, Inc. (NYSE:EVH) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 7,133 shares of the technology company’s stock, valued at approximately $236,000.

A number of other large investors have also modified their holdings of EVH. Nisa Investment Advisors LLC increased its stake in shares of Evolent Health by 389.3% in the third quarter. Nisa Investment Advisors LLC now owns 5,035 shares of the technology company’s stock valued at $137,000 after purchasing an additional 4,006 shares during the period. Strs Ohio increased its position in Evolent Health by 46.3% in the 4th quarter. Strs Ohio now owns 6,000 shares of the technology company’s stock valued at $198,000 after acquiring an additional 1,900 shares during the period. Teacher Retirement System of Texas raised its stake in Evolent Health by 9.0% during the 3rd quarter. Teacher Retirement System of Texas now owns 8,293 shares of the technology company’s stock valued at $226,000 after acquiring an additional 685 shares in the last quarter. Altshuler Shaham Ltd boosted its position in Evolent Health by 25.0% during the 3rd quarter. Altshuler Shaham Ltd now owns 15,000 shares of the technology company’s stock worth $408,000 after acquiring an additional 3,000 shares during the period. Finally, Amalgamated Bank grew its stake in shares of Evolent Health by 9.7% in the third quarter. Amalgamated Bank now owns 17,023 shares of the technology company’s stock worth $464,000 after purchasing an additional 1,500 shares in the last quarter.

Evolent Health Stock Down 2.4 %

Shares of Evolent Health stock opened at $27.65 on Monday. Evolent Health, Inc. has a 12-month low of $23.33 and a 12-month high of $36.70. The firm has a market capitalization of $3.19 billion, a PE ratio of -21.77 and a beta of 1.53. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.56. The stock’s fifty day moving average is $31.77 and its 200-day moving average is $30.29.

Evolent Health (NYSE:EVH) last issued its quarterly earnings results on Thursday, February 22nd. The technology company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.13. Evolent Health had a positive return on equity of 6.60% and a negative net margin of 5.76%. The firm had revenue of $556.06 million for the quarter, compared to analysts’ expectations of $541.87 million. Equities analysts anticipate that Evolent Health, Inc. will post 0.87 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Canaccord Genuity Group reduced their price objective on shares of Evolent Health from $45.00 to $44.00 and set a “buy” rating for the company in a report on Thursday, March 28th. JMP Securities increased their price objective on shares of Evolent Health from $37.00 to $38.00 and gave the company a “market outperform” rating in a report on Friday, February 23rd. JPMorgan Chase & Co. dropped their target price on Evolent Health from $53.00 to $52.00 and set an “overweight” rating on the stock in a report on Friday, March 15th. Citigroup began coverage on Evolent Health in a research note on Monday, April 22nd. They set a “buy” rating and a $40.00 price target for the company. Finally, Barclays assumed coverage on Evolent Health in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $39.00 price objective on the stock. One research analyst has rated the stock with a sell rating, one has given a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $42.70.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.